| Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC C Hu, B Xu, X Wang, WH Wan, J Lu, D Kong, Y Jin, W You, H Sun, X Mu, ... Hepatology 77 (1), 48-64, 2023 | 51 | 2023 |
| Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer R Peng, S Liu, W You, Y Huang, C Hu, Y Gao, X Jia, G Li, Z Xu, Y Chen Cancer immunology research 10 (10), 1224-1240, 2022 | 31 | 2022 |
| PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells Q Li, L Zhang, W You, J Xu, J Dai, D Hua, R Zhang, F Yao, S Zhou, ... Nature communications 13 (1), 7677, 2022 | 24 | 2022 |
| Implications of cardiac markers in risk-stratification and management for COVID-19 patients P Li, W Wu, T Zhang, Z Wang, J Li, M Zhu, Y Liang, W You, K Li, R Ding, ... Critical Care 25, 1-14, 2021 | 20 | 2021 |
| Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling P Wang, M Ni, Y Tian, H Wang, J Qiu, W You, S Wei, Y Shi, J Zhou, ... IScience 24 (5), 2021 | 17 | 2021 |
| Implications of liver injury in risk-stratification and management of patients with COVID-19 J Shao, Y Liang, Y Li, R Ding, M Zhu, W You, Z Wang, B Huang, M Wu, ... Hepatology international 15, 202-212, 2021 | 17 | 2021 |
| Single-cell RNA-seq reveals transcriptional landscape and intratumor heterogenicity in gallbladder cancer liver metastasis microenvironment Y Zhang, WH You, X Li, P Wang, B Sha, Y Liang, J Qiu, J Zhou, H Hu, ... Annals of Translational Medicine 9 (10), 2021 | 11 | 2021 |
| Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy L Shi, J Lu, D Zhong, M Song, J Liu, W You, WH Li, L Lin, D Shi, Y Chen Journal for immunotherapy of cancer 11 (1), 2023 | 9 | 2023 |
| Association of blood glucose level and prognosis of inpatients with coexistent diabetes and COVID-19 W Duan, L Li, X Li, M Zhu, L Wu, W Wu, K Li, Y Liang, R Ding, W You, ... Endocrine, 1-9, 2022 | 7 | 2022 |
| Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma L Zhang, J Xu, S Zhou, F Yao, R Zhang, W You, J Dai, K Yu, Y Zhang, ... Journal of Hepatology 80 (1), 82-98, 2024 | 6 | 2024 |
| Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma X Gan, W Dong, W You, D Ding, Y Yang, D Sun, W Li, W Ding, Y Liang, ... Cancer Letters 581, 216513, 2024 | 2 | 2024 |
| Pan-cancer analysis identifies tumor cell surface targets for CAR-T cell therapies and antibody drug conjugates X Li, J Zhou, W Zhang, W You, J Wang, L Zhou, L Liu, WW Chen, H Li Cancers 14 (22), 5674, 2022 | 2 | 2022 |
| Pathogenesis and clinical translation of intrahepatic cholangiocarcinoma in the era of precision medicine YOU Wenhua, Y LIANG, LYU Ling 临床肝胆病杂志 37 (4), 935-938, 2021 | 2 | 2021 |
| An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure W Liu, W You, Z Lan, Y Ren, S Gao, S Li, WW Chen, C Huang, Y Zeng, ... Cell Reports Medicine 5 (3), 2024 | | 2024 |
| Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13+ CD103+ CD8+ Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer … C Hu, W You, D Kong, Y Huang, JY Lu, M Zhao, Y Jin, R Peng, D Hua, ... Gastroenterology, 2023 | | 2023 |
yuan liangSoutheast UniversityVerified email at seu.edu.cn
